chr12-64688288-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_178169.4(RASSF3):āc.292A>Gā(p.Asn98Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000719 in 1,614,124 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_178169.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RASSF3 | NM_178169.4 | c.292A>G | p.Asn98Asp | missense_variant | 3/5 | ENST00000542104.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RASSF3 | ENST00000542104.6 | c.292A>G | p.Asn98Asp | missense_variant | 3/5 | 1 | NM_178169.4 | P2 | |
RASSF3 | ENST00000637125.1 | c.475A>G | p.Asn159Asp | missense_variant | 4/6 | 5 | A2 | ||
RASSF3 | ENST00000283172.8 | c.220-3182A>G | intron_variant, NMD_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000361 AC: 55AN: 152146Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000107 AC: 27AN: 251464Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135902
GnomAD4 exome AF: 0.0000417 AC: 61AN: 1461860Hom.: 1 Cov.: 32 AF XY: 0.0000468 AC XY: 34AN XY: 727228
GnomAD4 genome AF: 0.000361 AC: 55AN: 152264Hom.: 0 Cov.: 32 AF XY: 0.000403 AC XY: 30AN XY: 74448
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 12, 2021 | The c.292A>G (p.N98D) alteration is located in exon 3 (coding exon 3) of the RASSF3 gene. This alteration results from a A to G substitution at nucleotide position 292, causing the asparagine (N) at amino acid position 98 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at